They found that for FDA approved GLP-1s for weight loss, liraglutide (Saxenda) and semaglutide (Wegovy), the percent of side effects reported was as follows: Nausea: 42.2% Diarrhea: 21.9% Vomiting: also 21.9% Constipation: 8.4% They report that although the incidence of side effects were similar among medications, semaglutide had the greatest risk of nausea, diarrhea, and vomiting, whereas liraglutide had the greatest risk of upper abdominal pain
Clinical Studies and Results Clinical trials have consistently shown the efficacy of GLP-1 agonists for weight loss
The American Journal of Clinical Nutrition, 120 (5), 1245-1258
Why It Appears Legitimate The company provides contact details, secure checkout, and a transparent refund policy
Several contenders are already in development, as pharmaceutical companies race to find better drugs for weight loss
Pen-format search page that routes visitors to the live Retatrutide 40mg product page and support information
